1 1933 157 ROLE OF YOGA IN MODIFYING CERTAIN CARDIOVASCULAR FUNCTIONS IN TYPE 2 DIABETIC PATIENTS. OBJECTIVES: 1. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON CARDIAC FUNCTIONS IN TYPE 2 DIABETICS. 2. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON BLOOD GLUCOSE LEVEL, GLYCOSYLATED HEMOGLOBIN. METHODS: THE PRESENT STUDY DONE IN TWENTY-FOUR TYPE 2 DM CASES PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND AUTONOMIC FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH AUTONOMIC FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND THEY PURSUED THOSE 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. RESULTS: THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS FROM BASAL 190.08 +/- 18.54 IN MG/DL TO 141.5 +/- 16.3 IN MG/DL AFTER YOGA REGIMEN. THE POST PRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 276.54 +/- 20.62 IN MG/DL TO 201.75 +/- 21.24 IN MG/DL, GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE FROM 9.03 +/- 0.29% TO 7.83 +/- 0.53% AFTER YOGA REGIMEN. THE PULSE RATE, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE DECREASED SIGNIFICANTLY (FROM 86.45 +/- 2.0 TO 77.65 +/- 2.5 PULSE/MIN, FROM 142.0 +/- 3.9 TO 126.0 +/- 3.2 MM OF HG AND FROM 86.7 +/- 2.5 MM OF HG TO 75.5 +/- 2.1 MM OF HG AFTER YOGA REGIMEN RESPECTIVELY). CORRECTED QT INTERVAL (QTC) DECREASED FROM 0.42 +/- 0.0 TO 0.40 +/- 0.0. CONCLUSION: THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND STABLE AUTONOMIC FUNCTIONS CAN BE OBTAINED IN TYPE 2 DM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND AUTONOMIC FUNCTIONS REMAINS TO BE WORKED OUT. 2004 2 2007 101 STUDY OF YOGA ASANAS IN ASSESSMENT OF PULMONARY FUNCTION IN NIDDM PATIENTS. CERTAIN YOGA ASANAS IF PRACTICED REGULARLY ARE KNOWN TO HAVE BENEFICIAL EFFECTS ON HUMAN BODY. THESE YOGA PRACTICES MIGHT BE INTERACTING WITH VARIOUS, SOMATO-NEURO-ENDOCRINE MECHANISMS TO HAVE THERAPEUTIC EFFECTS. THE PRESENT STUDY DONE IN TWENTY FOUR NIDDM PATIENTS OF 30 TO 60 YEAR OLD, PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH PULMONARY FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND WERE PURSED 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS (BASAL 190.08 +/- 90.8 IN MG/DL TO 141.5 +/- 79.8 IN MG/DL). THE POSTPRANDIAL BLOOD GLUCOSE LEVELS ALSO DECREASED (276.54 +/- 101.0 IN MG/DL TO 201.75 +/- 104.1 IN MG/DL), GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE (9.03 +/- 1.4% TO 7.83 +/- 2.6%). THE FEV1, FVC, PEFR, MVV INCREASED SIGNIFICANTLY (1.81 +/- 0.4 LT TO 2.08 +/- 0.4 LT, 2.20 +/- 0.6 LT TO 2.37 +/- 0.5 LT, 3.30 +/- 1.0 LT/S TO 4.43 +/- 1.4 LT/S AND 64.59 +/- 25.7 LT MIN TO 76.28 +/- 28.1 LT/MIN RESPECTIVELY). FEV1/FVC% IMPROVED (85 +/- 0.2% TO 89 +/- 0.1%). THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS CAN BE OBTAINED IN NIDDM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING, INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND PULMONARY FUNCTIONS REMAINS TO BE WORKED OUT. 2002 3 138 42 A PRELIMINARY REPORT ON THE ROLE OF YOGA ASANAS ON OXIDATIVE STRESS IN NON-INSULIN DEPENDENT DIABETES MELLITUS. NINETEEN SUBJECTS OF NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) BETWEEN THE AGE GROUP OF 30-60 YRS WERE STUDIED TO SEE THE EFFECT OF SPECIFIC YOGA ASANAS ON FASTING AND POSTPRANDIAL BLOOD GLUCOSE (FBG, PPG), SERUM MALONDIALDEHYDE (MDA) AND GLYCOSYLATED HEMOGLOBIN (HBA(1)) IN ADDITION TO DRUG TREATMENT AND DIET CONTROL. THE DURATION OF DIABETES RANGED FROM 1-10 YEARS. PATIENTS WITH RENAL, CARDIAC AND PROLIFERATIVE RETINAL DISEASES WERE EXCLUDED FROM THE STUDY. THE SAME PATIENTS SERVED AS THEIR OWN CONTROL. SUBJECTS WERE CALLED IN THE MORNING TO THE CARDIO-RESPIRATORY LABORATORY AND WERE GIVEN TRAINING BY A YOGA EXPERT. YOGA ASANAS INCLUDED SURYANAMSKAR, TADASAN, TRIKONASAN, PADMASAN, PRANAYAM, PASCHIMOTTANASAN, ARDHMATSYENDRASAN, PAVANMUKTHASAN, SARPASAN AND SHAVASAN. THE ASANAS WERE DONE EVERY DAY FOR 40 DAYS FOR 30-40 MIN. FBG, PPG, SERUM MDA AND HBA(1) WERE ESTIMATED BEFORE AND AFTER 40 DAYS OF YOGA ASANAS REGIMEN. SIGNIFICANT REDUCTION WAS SEEN IN FBG FROM 220 MG/DL TO 162 MG/DL, PPG FROM 311 MG/DL TO 255 MG/DL, MDA FROM 6 NMOL/L TO 3 NMOL/L AND HBA(1), FROM 8.8% TO 6.4%. SUBJECTS FELT BETTER AND WERE RELIEVED OF THEIR STRESSES AND HAD AN IMPROVEMENT IN THEIR DAY TO DAY PERFORMANCE. THE DECREASE WAS STATISTICALLY SIGNIFICANT (P<0.0001 FOR FBG AND PPG, P<0.001 FOR MDA AND FOR HBA(1)). 2001 4 1453 36 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 5 895 40 EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. DIABETES IS A METABOLIC DISORDER, WHICH HAS BECOME A MAJOR HEALTH CHALLENGE WORLDWIDE. SOUTH EAST ASIAN COUNTRIES HAVE A HIGHEST BURDEN OF DIABETES. IN INDIA THE PREVALENCE OF DIABETES IS RISING RAPIDLY ESPECIALLY IN THE URBAN POPULATION BECAUSE OF INCREASING OBESITY AND REDUCED PHYSICAL ACTIVITY. AN OBJECTIVE OF THIS STUDY IS TO EVALUATE THE EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. THIS STUDY WAS CONDUCTED ON 41, MIDDLE AGED, TYPE-2 DIABETIC PATIENTS, WHO WERE ON ORAL HYPOGLYCAEMIC. THESE PATIENTS WERE DIVIDED IN TO TWO GROUPS: (A) 20 PATIENTS ON ORAL HYPOGLYCAEMIC WITH YOGA-NIDRA, AND (B) 21 WERE ON ORAL HYPOGLYCAEMIC ALONE. YOGA-NIDRA PRACTICED FOR 30 MINUTES DAILY UP TO 90 DAYS, PARAMETERS WERE RECORDED EVERY. 30TH DAY. RESULTS OF THIS STUDY SHOWED THAT MOST OF THE SYMPTOMS WERE SUBSIDED (P < 0.004, SIGNIFICANT), AND FALL OF MEAN BLOOD GLUCOSE LEVEL WAS SIGNIFICANT AFTER 3-MONTH OF YOGA-NIDRA. THIS FALL WAS 21.3 MG/DL, P < 0.0007, (FROM 159 +/- 12.27 TO 137.7 +/- 23.15,) IN FASTING AND 17.95 MG/DL, P = 0.02, (FROM 255.45 +/- 16.85 TO 237.5 +/- 30.54) IN POST PRANDIAL GLUCOSE LEVEL. RESULTS OF THIS STUDY SUGGEST THAT SUBJECTS ON YOGA-NIDRA WITH DRUG REGIMEN HAD BETTER CONTROL IN THEIR FLUCTUATING BLOOD GLUCOSE AND SYMPTOMS ASSOCIATED WITH DIABETES, COMPARED TO THOSE WERE ON ORAL HYPOGLYCAEMICS ALONE. 2009 6 781 44 EFFECT OF YOGA ASANAS ON NERVE CONDUCTION IN TYPE 2 DIABETES. TWENTY TYPE 2 DIABETIC SUBJECTS BETWEEN THE AGE GROUP OF 30-60 YEARS WERE STUDIED TO SEE THE EFFECT OF 40 DAYS OF YOGA ASANAS ON THE NERVE CONDUCTION VELOCITY. THE DURATION OF DIABETES RANGED FROM 0-10 YEARS. SUBJECT SUFFERING FROM CARDIAC, RENAL AND PROLIFERATIVE RETINAL COMPLICATIONS WERE EXCLUDED FROM THE STUDY YOGA ASANAS INCLUDED SURYANAMSKAR. TADASAN, KONASAN, PADMASAN PRANAYAM, PASCHIMOTTANSAN ARDHMATSYENDRASAN, SHAVASAN, PAVANMUKTHASAN, SARPASAN AND SHAVASAN. SUBJECTS WERE CALLED TO THE CARDIO-RESPIRATORY LABORATORY IN THE MORNING TIME AND WERE GIVEN TRAINING BY THE YOGA EXPERT. THE YOGA EXERCISES WERE PERFORMED FOR 30-40 MINUTES EVERY DAY FOR 40 DAYS IN THE ABOVE SEQUENCE. THE SUBJECTS WERE PRESCRIBED CERTAIN MEDICINES AND DIET. THE BASAL BLOOD GLUCOSE, NERVE CONDUCTION VELOCITY OF THE MEDIAN NERVE WAS MEASURED AND REPEATED AFTER 40 DAYS OF YOGIC REGIME. ANOTHER GROUP OF 20 TYPE 2 DIABETES SUBJECTS OF COMPARABLE AGE AND SEVERITY, CALLED THE CONTROL GROUP, WERE KEPT ON PRESCRIBED MEDICATION AND LIGHT PHYSICAL EXERCISES LIKE WALKING. THEIR BASAL & POST 40 DAYS PARAMETERS WERE RECORDED FOR COMPARISON. RIGHT HAND AND LEFT HAND MEDIAN NERVE CONDUCTION VELOCITY INCREASED FROM 52.81 +/- 1.1 M/SEC TO 53.87 +/- 1.1 M/SEC AND 52.46 +/- 1.0 TO 54.75 +/- 1/1 M/SEC RESPECTIVELY. CONTROL GROUP NERVE FUNCTION PARAMETERS DETERIORATED OVER THE PERIOD OF STUDY, INDICATING THAT DIABETES IS A SLOWLY PROGRESSIVE DISEASE INVOLVING THE NERVES. YOGA ASANAS HAVE A BENEFICIAL EFFECT ON GLYCAEMIC CONTROL AND IMPROVE NERVE FUNCTION IN MILD TO MODERATE TYPE 2 DIABETES WITH SUB-CLINICAL NEUROPATHY. 2002 7 867 48 EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY IN CORONARY ARTERY DISEASE PATIENTS: A RANDOMIZED CONTROLLED STUDY. BACKGROUND: LUNG FUNCTIONS ARE FOUND TO BE IMPAIRED IN CORONARY ARTERY DISEASE (CAD), CONGESTIVE HEART FAILURE, LEFT VENTRICULAR DYSFUNCTION, AND AFTER CARDIAC SURGERY. DIFFUSION CAPACITY PROGRESSIVELY WORSENS AS THE SEVERITY OF CAD INCREASES DUE TO REDUCTION IN LUNG TISSUE PARTICIPATING IN GAS EXCHANGE. AIMS AND OBJECTIVES: PRANAYAMA BREATHING EXERCISES AND YOGIC POSTURES MAY PLAY AN IMPRESSIVE ROLE IN IMPROVING CARDIO-RESPIRATORY EFFICIENCY AND FACILITATING GAS DIFFUSION AT THE ALVEOLO-CAPILLARY MEMBRANE. THIS STUDY WAS DONE TO SEE THE EFFECT OF YOGA REGIMEN ON LUNG FUNCTIONS PARTICULARLY DIFFUSION CAPACITY IN CAD PATIENTS. MATERIALS AND METHODS: A TOTAL OF 80 STABLE CAD PATIENTS BELOW 65 YEARS OF AGE OF BOTH SEXES WERE SELECTED AND RANDOMIZED INTO TWO GROUPS OF 40 EACH. GROUP I CAD PATIENTS WERE GIVEN YOGA REGIMEN FOR 3 MONTHS WHICH CONSISTED OF YOGIC POSTURES, PRANAYAMA BREATHING EXERCISES, DIETARY MODIFICATION, AND HOLISTIC TEACHING ALONG WITH THEIR CONVENTIONAL MEDICINE WHILE GROUP II CAD PATIENTS WERE PUT ONLY ON CONVENTIONAL MEDICINE. LUNG FUNCTIONS INCLUDING DIFFUSION CAPACITY WERE RECORDED THRICE IN BOTH THE GROUPS: 0 DAY AS BASELINE, 22(ND) DAY AND ON 90(TH) DAY BY USING COMPUTERIZED MS MEDISOFT CARDIO-RESPIRATORY INSTRUMENT, HYP'AIR COMPACT MODEL OF CARDIO-RESPIRATORY TESTING MACHINE WAS MANUFACTURED BY P K MORGAN, INDIA. THE RECORDED PARAMETERS WERE STATISTICALLY ANALYZED BY REPEATED MEASURES ANOVA FOLLOWED BY TUKEY'S TEST IN BOTH THE GROUPS. CARDIOVASCULAR PARAMETERS WERE ALSO COMPARED BEFORE AND AFTER INTERVENTION IN BOTH THE GROUPS. RESULTS: STATISTICALLY SIGNIFICANT IMPROVEMENTS WERE SEEN IN SLOW VITAL CAPACITY, FORCED VITAL CAPACITY, PEAK EXPIRATORY FLOW RATE, MAXIMUM VOLUNTARY VENTILATION, AND DIFFUSION FACTOR/ TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE AFTER 3 MONTHS OF YOGA REGIMEN IN GROUP I. FORCED EXPIRATORY VOLUME IN 1(ST) SEC (FEV1), AND FEV1 % ALSO SHOWED A TREND TOWARD IMPROVEMENT ALTHOUGH NOT STATISTICALLY SIGNIFICANT. HR, SBP AND DBP ALSO SHOWED SIGNIFICANT IMPROVEMENT IN GROUP-I PATIENTS WHO FOLLOWED YOGA REGIMEN. CONCLUSIONS: YOGA REGIMEN WAS FOUND TO IMPROVE LUNG FUNCTIONS AND DIFFUSION CAPACITY IN CAD PATIENTS BESIDES IMPROVING CARDIOVASCULAR FUNCTIONS. THUS, IT CAN BE USED AS A COMPLIMENTARY OR ADJUNCT THERAPY ALONG WITH THE CONVENTIONAL MEDICINE FOR THEIR TREATMENT AND REHABILITATION. 2015 8 823 41 EFFECT OF YOGA ON GLUCOSE CONTROL AND QUALITY OF LIFE IN PATIENTS OF PREDIABETES. OBJECTIVE: THE OBJECTIVE OF THIS STUDY WAS TO EVALUATE EFFECT OF YOGA ON FASTING PLASMA GLUCOSE (FPG), POSTPRANDIAL PLASMA GLUCOSE, AND HEMOGLOBIN A1C (HBA1C) AND ALSO ON QUALITY OF LIFE (QOL). RESEARCH DESIGN AND METHODS: THIS WAS A COHORT STUDY IN WHICH 100 DIAGNOSED CASES OF PREDIABETES WERE RECRUITED FOR DOING SPECIFIC YOGA, AND THEY THEMSELVES ACT AS CONTROL FOR THE STUDY. THE MEASUREMENT AND COMPARISON OF FPG, PRANDIAL PLASMA GLUCOSE (PPG), AND HBA1C WERE DONE AT THREE DIFFERENT TIME INTERVALS, THAT IS, BASELINE, 3 MONTHS, AND AT 6 MONTHS. THE ASSESSMENT OF QOL WAS DONE USING SF-36 SCALE. RESULTS: ONE HUNDRED PREDIABETIC CASES WERE SELECTED FOR THE STUDY IN WHICH IMPAIRED FASTING GLUCOSE (IFG) WAS PRESENT MORE IN YOUNGER POPULATION COMPARED TO IMPAIRED GLUCOSE TOLERANCE (IGT) AND IFG PLUS IGT BOTH OF WHICH ARE MORE PREVALENT IN MIDDLE AGE GROUP. THE YOGA THERAPY WAS FOUND TO HAVE FAVORABLE EFFECT ON FPG, PPG, AND HBA1C ALONG WITH VARIOUS ANTHROPOMETRY MEASURES STUDIED IN THIS STUDY. AFTER ADJUSTING CORRELATION COEFFICIENT FOR VARIOUS ANTHROPOMETRY MEASURES, YOGA WAS FOUND TO BE EFFECTIVE FOR CONTROLLING GLYCEMIC PARAMETERS IN PREDIABETICS. CONCLUSIONS: YOGA IS A TYPE OF EXERCISE KNOWN TO IMPROVE GLYCEMIC CONTROL BY CHANGING ANTHROPOMETRY MEASURES, BUT OUR STUDY AIDS IN KNOWLEDGE ABOUT THE BENEFICIAL EFFECT BEYOND THIS KNOWN FACT THROUGH OTHER MECHANISMS YET TO BE EXPLORED. 2021 9 904 43 EFFECTIVENESS OF ADJUVANT YOGA THERAPY IN DIABETIC LUNG: A RANDOMIZED CONTROL TRIAL. CONTEXT: RECENT STUDIES PROVIDE AMPLE EVIDENCE OF THE BENEFITS OF YOGA IN VARIOUS CHRONIC DISORDERS. DIABETES MELLITUS IS A GROUP OF METABOLIC DISEASES CHARACTERIZED BY CHRONIC HYPERGLYCEMIA AND SANDLER COINED THE TERM "DIABETIC LUNG" FOR THE ABNORMAL PULMONARY FUNCTION DETECTED IN DIABETIC PATIENTS DUE UNDERLYING PULMONARY DYSFUNCTION. YOGA THERAPY MAY HELP IN ACHIEVING BETTER PULMONARY FUNCTION ALONG WITH ENHANCED GLYCAEMIC CONTROL AND OVERALL HEALTH BENEFITS. AIM: TO STUDY THE EFFECT OF ADJUVANT YOGA THERAPY IN DIABETIC LUNG THROUGH SPIROMETRY. SETTINGS AND DESIGN: RANDOMIZED CONTROL TRIAL WAS MADE AS INTERDISCIPLINARY COLLABORATIVE WORK BETWEEN DEPARTMENTS OF YOGA THERAPY, PULMONARY MEDICINE AND ENDOCRINOLOGY, OF MGMC & RI, SRI BALAJI VIDYAPEETH PUDUCHERRY. MATERIALS AND METHODS: 72 PATIENTS OF DIABETIC LUNG AS CONFIRMED BY SPIROMETRY (<70% OF EXPECTED) WERE RANDOMIZED INTO CONTROL GROUP (N=36) WHO RECEIVED ONLY STANDARD MEDICAL TREATMENT AND YOGA GROUP (N=36) WHO RECEIVED YOGA TRAINING THRICE WEEKLY FOR 4 MONTHS ALONG WITH STANDARD MEDICAL MANAGEMENT. YOGA THERAPY PROTOCOL INCLUDED YOGIC COUNSELING, PREPARATORY PRACTICES, ASANAS OR STATIC POSTURES, PRANAYAMA OR BREATHING TECHNIQUES AND RELAXATION TECHNIQUES. HATHENAS OF THE GITANANDA YOGA TRADITION WERE THE MAIN PRACTICES USED. SPIROMETRY WAS DONE AT THE END OF THE STUDY PERIOD. DATA WAS ANALYZED BY STUDENT'S PAIRED AND UNPAIRED 'T' TEST AS IT PASSED NORMALITY. RESULTS: THERE WAS A STATISTICALLY SIGNIFICANT (P < 0.05) REDUCTION IN WEIGHT, AND BMI ALONG WITH A SIGNIFICANT (P < 0.01) IMPROVEMENT IN PULMONARY FUNCTION (FEV1, FVC) IN YOGA GROUP AS COMPARED TO CONTROL GROUP WHERE PARAMETERS WORSENED OVER STUDY PERIOD. CONCLUSION: IT IS CONCLUDED FROM THE PRESENT RCT THAT YOGA HAS A DEFINITE ROLE AS AN ADJUVANT THERAPY AS IT ENHANCES STANDARD MEDICAL CARE AND HENCE IS EVEN MORE SIGNIFICANT IN ROUTINE CLINICAL MANAGEMENT OF DIABETES, IMPROVING PHYSICAL CONDITION AND PULMONARY FUNCTION. 2019 10 213 29 A STUDY OF RESPONSE PATTERN OF NON-INSULIN DEPENDENT DIABETICS TO YOGA THERAPY. CHANGES IN BLOOD GLUCOSE AND GLUCOSE TOLERANCE BY ORAL GLUCOSE TOLERANCE TEST (OGTT) AFTER 40 DAYS OF YOGA THERAPY IN 149 NON-INSULIN-DEPENDENT DIABETICS (NIDDM) WERE INVESTIGATED. THE RESPONSE TO YOGA IN THESE SUBJECTS WAS CATEGORIZED ACCORDING TO A SEVERITY SCALE INDEX (SSI) BASED ON AREA INDEX TOTAL (AIT) UNDER OGTT CURVE. ONE HUNDRED AND FOUR PATIENTS SHOWED A FAIR TO GOOD RESPONSE TO THE YOGA THERAPY. THERE WAS A SIGNIFICANT REDUCTION IN HYPERGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIC DRUGS REQUIRED FOR MAINTENANCE OF NORMOGLYCEMIA. IT IS CONCLUDED THAT YOGA, A SIMPLE AND ECONOMICAL THERAPY, MAY BE CONSIDERED A BENEFICIAL ADJUVANT FOR NIDDM PATIENTS. 1993 11 1938 32 ROLE OF YOGA ON CARDIC AUTONOMIC FUNCTION TESTS AND COGNITION IN TYPE 2 DIABETES. ACCORDING TO INTERNATIONAL DIABETIC FEDERATION, TYPE 2 DIABETIC POPULATION IS ON THE RISE GLOBALLY AND COGNITIVE DECLINE IS ONE OF THE COMPLICATIONS SEEN IN TYPE 2 DIABETES. THE PRESENT STUDY IS AIMED AT EXPLORING THE ROLE OF REGULAR PRACTICE OF YOGA ON COGNITION IN TYPE 2 DIABETES AND ALSO TO STUDY THE RELATION BETWEEN THE COGNITION AND FUNCTIONAL STATUS OF AUTONOMIC NERVOUS SYSTEM BY CONSIDERING THE CARDIAC AUTONOMIC (CAN) FUNCTION TESTS. TEN TYPE 2 DIABETIC SUBJECTS OF BOTH THE SEX, AGED BETWEEN 35-55 YEARS, WHO PRACTICED YOGA FOR A PERIOD OF SIX MONTHS AT YOGI VEMANA YOGA RESEARCH INSTITUTE WERE RECRUITED AS TEST GROUP. AGE AND SEX MATCHED TEN TYPE 2 DIABETIC SUBJECTS WERE RECRUITED AS CONTROL GROUP; BOTH THE GROUP SUBJECTS ARE ON ORAL HYPOGLYCEMIC AGENTS. GLYCOSYLATED HEMOGLOBIN CONCENTRATION WAS ESTIMATED WITH BIO-RAD INSTRUMENT, COGNITION WAS ASSESSED WITH ADDENBROOKE'S COGNITIVE EXAMINATION REVISED BATTERY AND CARDIAC AUTONOMIC FUNCTION TESTS WERE ALSO CONDUCTED. UNPAIRED STUDENT T TEST WAS PERFORMED AND P<0.05 IS CONSIDERED STATISTICALLY SIGNIFICANT. THE MEAN HBA1C CONCENTRATION IN CONTROL AND TEST GROUP SUBJECTS IS 7.8+/-1.84 AND 6.9+/-0.4% (P=0.03) RESPECTIVELY. MEAN COGNITIVE SCORES IN TEST AND CONTROL GROUP SUBJECTS ARE 93+/-4.5 AND 85+/-4.0 (P=0.008) RESPECTIVELY. CAN TEST RESULTS DIDN'T SHOWED ANY SIGNIFICANCE BETWEEN THE TEST AND CONTROL GROUP. BUT CAN FUNCTIONS ARE AFFECTED IN BOTH THE GROUPS. REGULAR PRACTICE OF YOGA IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS HAS A POSITIVE EFFECT ON COGNITION IN TYPE 2 DIABETES. 2015 12 2153 27 THE EFFECTS OF SUDARSHAN KRIYA YOGA ON SOME PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS IN MILD HYPERTENSIVE PATIENTS. AN OPEN LABEL INTERVENTION STUDY WAS UNDERTAKEN ON 26 MILD HYPERTENSIVES AND 26 APPARENTLY HEALTHY ADULTS (30-60 Y), FOR THE EFFECT OF SUDARSHAN KRIYA YOGA PRACTICE FOR TWO MONTHS AS COMPLEMENTARY THERAPY. IN THE HYPERTENSIVES, THERE WAS A SIGNIFICANT DECREASE IN DIASTOLIC BLOOD PRESSURE (P < 0.01), SERUM UREA (P < 0.01) AND PLASMA MDA (MALONDIALDEHYDE ADDUCTS) AS OXIDATIVE STRESS MARKER (P < 0.05). OTHER PARAMETERS; VIZ.; PLASMA LEVELS OF CHOLESTEROL, TRIGLYCERIDES, GLUCOSE, DID NOT CHANGE SIGNIFICANTLY (P > 0.1). THE PATTERN OF CHANGE IN MOST OF THE STUDY PARAMETERS WAS SUCH THAT VALUES ABOVE NORMAL RANGE WERE LOWERED BUT VALUES WITHIN NORMAL RANGE WERE UNALTERED. THE ACTION OF YOGA ON DIASTOLIC BLOOD PRESSURE, MALONDIALDEHYDE ADDUCTS AND KIDNEY FUNCTION IN HYPERTENSIVES WAS OF COUNTERACTIVE NATURE AND FELT TO BE DISTINCTLY DIFFERENT THAN THE EFFECT OF DRUGS. 2011 13 1928 36 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007 14 2006 41 STUDY OF THE EFFECT OF YOGA TRAINING ON DIFFUSION CAPACITY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE PATIENTS: A CONTROLLED TRIAL. BACKGROUND: PATIENTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ARE AT HIGH RISK FOR DEPRESSION AND ANXIETY. YOGA TECHNIQUES ARE SUITED FOR PROMOTING RELAXATION, PSYCHO-EMOTIONAL STABILITY AND EXERCISE TOLERANCE. STUDIES SHOWING THE EFFECT OF YOGA IN DIFFUSION CAPACITY ARE NOT AVAILABLE; HENCE THIS STUDY WAS PLANNED. MATERIALS AND METHODS: THE STUDY WAS CONDUCTED ON 60 DIAGNOSED STABLE MILD-TO-MODERATE COPD PATIENTS IN THE AGE GROUP OF 30-60 YEARS, OF EITHER SEX, IN THE DEPARTMENT OF PHYSIOLOGY. PATIENTS WERE TAKEN FROM GURU TEG BAHADUR HOSPITAL, DELHI AND DIVIDED INTO TWO GROUPS: CONTROL AND THE YOGA GROUP. BOTH THE GROUPS WERE ON CONVENTIONAL DRUG THERAPY. SUBJECTS FROM THE YOGA GROUP WAS CALLED TO CARDIOPULMONARY LABORATORY DAILY FOR 21 DAYS AND THEN WEEKLY FOR THE COMPLIANCE. YOGA INSTRUCTOR TAUGHT THEM THE TECHNIQUE OF PRANAYAMA AND VARIOUS POSTURES EVERY DAY. THEY PRACTICED YOGA AT HOME FOR 2 MONTHS FOR 45 MIN IN THE MORNINGS. DIFFUSION CAPACITY WAS RECORDED BY USING COMPUTERIZED MEDISOFT INSTRUMENT (HYPAIR COMPACT), IN BOTH THE GROUPS BEFORE AND AFTER 2 MONTHS. RESULTS: STATISTICAL ANALYSIS SHOWED SIGNIFICANT IMPROVEMENT IN TLCO OF THE YOGA GROUP. TRANSFER FACTOR OF LUNG FOR CARBON MONOXIDE I.E. TLCO IN MILD COPD INCREASED FROM 17.61 +/- 4.55 TO 19.08 +/- 5.09 ML/MMHG/MIN, AND IN MODERATE COPD IT INCREASED FROM 14.99 +/- 4.02 TO17.35 +/- 3.97 ML/MMHG/MIN. CONCLUSION: IT WAS CONCLUDED THAT YOGIC BREATHING EXERCISES IMPROVE DIFFUSION CAPACITY. THEY ARE BENEFICIAL TO COPD PATIENTS AND THEY CAN BE USED AS AN ADJUNCT THERAPY WITH THE CONVENTIONAL MEDICAL THERAPY. 2012 15 305 28 AN EVALUATION OF PULMONARY PARAMETERS IN TWO GROUPS OF SUBJECTS DURING YOGA PRACTICE. THE PURPOSE OF THE PRESENT STUDY WAS TO INVESTIGATE HOW FAR THE SHORT TERM PRACTICE OF YOGA (30 AND 60 DAYS) FOR AN HOUR DAILY CAN IMPROVE THE RESPIRATORY FUNCTION. MALE SUBJECTS (N=50, AGE 30-50 YEARS) WERE RANDOMLY SELECTED. RESPIRATORY PARAMETERS (FVC, FEV1, PEFR, FEF(25-75%) AND MVV) WERE DETERMINED BY USING A MULTIFUNCTIONAL COMPUTERIZED SPIROMETER. YOGA (POSTURE AND PRANAYAMAS) PRACTICE FOR A MONTH PRODUCED NO SIGNIFICANT IMPROVEMENT IN PULMONARY PARAMETERS. NEVERTHELESS, WHEN THE SUBJECTS CONTINUED IT FOR NEXT 30 DAYS, I.E., AFTER 60 DAYS SIGNIFICANT CHANGES WERE NOTED IN FVC (P<0.001), FEV, (P<0.01) AND PEFR (P<0.05). THE RESULT ALSO REVEALED THAT AMONGST THEM 30 DAYS YOGA TRAINING RESULTED IN A SIGNIFICANT INCREASE IN FVC IN ELDER GROUP OF PEOPLE (AGE 41-50 YRS) WHERE AS IN YOUNGER GROUP (AGE 30-40 YRS) THE CHANGES WERE NOT SO PROMINENT. RESULT INDICATED THAT SHORT TERM (30 DAYS) YOGA PRACTICE QUICKLY IMPROVES RESPIRATORY FUNCTIONS IN RELATIVELY ELDER PEOPLE (AGE 41-50 YRS), WHEN MANY OF THEM IN OUR TROPICAL COUNTRY SUFFER FROM PRIMARY LEVEL OF RESPIRATORY PROBLEM. REGULAR PRACTICE OF YOGA (POSTURE AND PRANAYAMAS) CAN PREVENT IT BY INCREASING THE EFFICACY OF RESPIRATORY MUSCLES. 2010 16 662 32 EFFECT OF 3-MONTH YOGA ON OXIDATIVE STRESS IN TYPE 2 DIABETES WITH OR WITHOUT COMPLICATIONS: A CONTROLLED CLINICAL TRIAL. OBJECTIVE: TO ASSESS THE EFFECT OF YOGA ON ANTHROPOMETRY, BLOOD PRESSURE, GLYCEMIC CONTROL, AND OXIDATIVE STRESS IN TYPE 2 DIABETIC PATIENTS ON STANDARD CARE IN COMPARISON WITH STANDARD CARE ALONE. RESEARCH DESIGN AND METHODS: THE STUDY INVOLVED 123 PATIENTS STRATIFIED ACCORDING TO GROUPS WITH MICROVASCULAR COMPLICATIONS, MACROVASCULAR COMPLICATIONS, AND PERIPHERAL NEUROPATHY AND WITHOUT COMPLICATIONS AND ASSIGNED TO RECEIVE EITHER STANDARD CARE OR STANDARD CARE ALONG WITH ADDITIONAL YOGA FOR 3 MONTHS. RESULTS: IN COMPARISON WITH STANDARD CARE ALONE, YOGA RESULTED IN SIGNIFICANT REDUCTION IN BMI, GLYCEMIC CONTROL, AND MALONDIALDEHYDE AND INCREASE IN GLUTATHIONE AND VITAMIN C. THERE WERE NO DIFFERENCES IN WAIST CIRCUMFERENCE, WAIST-TO-HIP RATIO, BLOOD PRESSURE, VITAMIN E, OR SUPEROXIDE DISMUTASE IN THE YOGA GROUP AT FOLLOW-UP. CONCLUSIONS: YOGA CAN BE USED AS AN EFFECTIVE THERAPY IN REDUCING OXIDATIVE STRESS IN TYPE 2 DIABETES. YOGA IN ADDITION TO STANDARD CARE HELPS REDUCE BMI AND IMPROVE GLYCEMIC CONTROL IN TYPE 2 DIABETIC PATIENTS. 2011 17 705 46 EFFECT OF INTEGRATED APPROACH OF YOGA THERAPY ON AUTONOMIC FUNCTIONS IN PATIENTS WITH TYPE 2 DIABETES. BACKGROUND AND OBJECTIVES: INTEGRATED APPROACH OF YOGA THERAPY (IAYT) HAD SHOWN BENEFICIAL EFFECTS IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS (DM). AUTONOMIC DYSFUNCTION IS ONE OF THE MAJOR COMPLICATIONS OF TYPE 2 DM. RESEARCH STUDIES HAVE DEMONSTRATED THAT YOGA CAN MODULATE AUTONOMIC FUNCTIONS. HENCE, THE CURRENT STUDY WAS DESIGNED TO ASSESS THE EFFECT OF IAYT ON AUTONOMIC FUNCTIONS IN TYPE 2 DIABETICS. MATERIALS AND METHODS: 15 PATIENTS OF TYPE 2 DM WITH AGES RANGING FROM 35 TO 60 YEARS WERE RECRUITED FOR THE STUDY. THEY WERE DIAGNOSED WITH TYPE 2 DIABETES FROM 1-YEAR TO 15 YEARS. ASSESSMENTS WERE MADE ON DAY 1 (BEFORE YOGA) AND DAY 7 (AFTER 1-WEEK OF YOGA PRACTICE). HEART RATE VARIABILITY (HRV), BLOOD PRESSURE (BP) RESPONSE TO THE ISOMETRIC HANDGRIP AND HEART RATE RESPONSE TO DEEP BREATHING WERE ASSESSED BEFORE AND AFTER 1-WEEK OF IAYT. RESULTS: THERE WAS A SIGNIFICANT REDUCTION IN FASTING PLASMA GLUCOSE FROM 154.67-130.27 MG/DL (WILCOXON SIGNED RANK TEST, P = 0.029) FOLLOWING 1-WEEK OF IAYT. BP RESPONSE TO ISOMETRIC HAND GRIP IMPROVED SIGNIFICANTLY (WILCOXON SIGNED RANK TEST, P = 0.01). THERE WAS NO STATISTICAL SIGNIFICANT CHANGE IN HRV COMPONENTS AND HEART RATE RESPONSE TO DEEP BREATHING TEST. HOWEVER, THERE WAS A TREND OF INCREASE IN THE LOW FREQUENCY POWER (41.07%), HIGH FREQUENCY POWER (6.29%), TOTAL POWER (5.38%), AND STANDARD DEVIATION OF ALL NN INTERVALS (SDNN) (6.29%). CONCLUSION: THESE FINDINGS SUGGEST THAT, IAYT IMPROVED AUTONOMIC FUNCTIONS IN TYPE 2 DIABETES PATIENTS. 2015 18 844 30 EFFECT OF YOGA ON PULMONARY FUNCTION TESTS OF HYPOTHYROID PATIENTS. AIM OF THIS STUDY WAS TO SEE ANY EFFECT ON RESPIRATORY FUNCTIONS IN HYPOTHYROID PATIENTS AFTER PRANAYAMA (YOGA). THE SUBJECTS FOR THE STUDY WERE 20 HYPOTHYROID FEMALES, 39.70 +/- 8.27 YEARS OF MEAN AGE REFERRED FROM MEDICINE DEPARTMENT OF UCMS & G.T.B. HOSPITAL. SPIRO METRIC RECORDINGS WERE TAKEN WITH HYPAIR (VERSION-1.28). BASELINE (FIRST) RECORDINGS WERE TAKEN WHEN PATIENT CAME FOR THE FIRST TIME. PATIENTS CAME TO YOGA LAB IN PHYSIOLOGY DEPARTMENT FOR 21 DAYS CONTINUOUSLY WHERE THEY WERE TRAINED BY THE YOGA INSTRUCTORS AND THEN TOLD TO DO PRANAYAMA AT HOME AND CALLED AT REGULAR INTERVALS AFTER 7 DAYS TO SEE THE COMPLIANCE. THE BREATHING EXERCISES WERE DONE FOR 45 MINUTES EVERYDAY. AFTER 6 MONTHS OF PRANAYAMA SECOND RECORDING WAS TAKEN AND COMPARED WITH THE BASELINE. THERE WERE SIGNIFICANT IMPROVEMENT IN FORCED EXPIRATORY VOLUME IN FIRST SECOND (FEV1), MAXIMUM VOLUNTARY VENTILATION (MVV) AND INSPIRATORY CAPACITY(IC). THUS PRANAYAMA AND MEDITATION HAS BENEFICIAL EFFECT ON PULMONARY FUNCTIONS OF HYPOTHYROID PATIENTS ALONG WITH CONVENTIONAL TREATMENT. 2010 19 2803 19 YOGA THERAPY IN CHRONIC BRONCHITIS. FIFTEEN PATIENTS OF CHRONIC BRONCHITIS RECEIVED YOGA THERAPY IN THE FORM OF PRANAYAM AND 8 TYPES OF 'ASANS' FOR A PERIOD OF 4 WEEKS. THEY HAD A PERCEPTIBLE IMPROVEMENT IN DYSPNOEA AS WAS MEASURED BY VISUAL ANALOG. LUNG FUNCTION PARAMETERS (VC, FEV1, AND PEFR) ALSO IMPROVED AFTER THE PRACTICE OF YOGA. THIS PRELIMINARY STUDY INDICATES THAT, YOGA MAY BE AN USEFUL ADJUNCT TO OTHER CONVENTIONAL FORM OF THERAPY FOR COPD. 1998 20 1929 29 ROLE OF YOGA IN MANAGEMENT OF ESSENTIAL HYPERTENSION. TWENTY FIVE PATIENTS OF ESSENTIAL HYPERTENSION WERE STUDIED. OF THESE, 20 PATIENTS WERE NOT GIVEN ANY ANTIHYPERTENSIVE DRUG TREATMENT (GROUP A); OTHER 5 HAD TO BE PUT ON ANTIHYPERTENSIVE DRUGS BEFORE INCLUDING THEM IN THE STUDY (GROUP B). THESE PATIENTS WERE DEMONSTRATED "SHAVASANA" AND TRAINED TO PERFORM IT CORRECTLY. SHAVASANA THERAPY WAS CONTINUED FOR SIX MONTHS. THERE WAS A STATISTICALLY SIGNIFICANT FALL IN BOTH MEAN SYSTOLIC AND DIASTOLIC PRESSURE OF BOTH GROUPS. FURTHER, THERE WAS A SIGNIFICANT REDUCTION IN DOSES OF ANTIHYPERTENSIVE DRUGS, BEING GIVEN TO PATIENTS OF GROUP B. IN 65% PATIENTS OF GROUP A, BLOOD PRESSURE COULD BE CONTROLLED WITH SHAVASANA ONLY AND NO DRUG WAS NEEDED IN THEM AT ALL. BLOOD PRESSURE ROSE SIGNIFICANTLY TO PRE-SHAVASANA LEVELS IN PATIENTS WHO LEFT PRACTISING YOGA. THUS, WITH USE OF YOGA (SHAVASANA) IN THERAPY OF HYPERTENSION, REQUIREMENT OF ANTIHYPERTENSIVE DRUGS MAY BE SIGNIFICANTLY DECREASED AND IN SOME CASES MAY BE TOTALLY DISPENSED WITH AND IT MAY BE AN USEFUL ADJUNCT IN TREATMENT OF HYPERTENSION. 1984